mhurhangee/ep-ind-claims huggingface dataset:
A system for providing an assistive driving force to a wheelchair comprising: (a) a power assist system comprising a motion sensing system configured to detect the motion of the power assist system, and a power assist drive system; characterized in that it further comprises (b) a sensor configured to detect a motion of a user's hand, the sensor being in communication with the power assist system. (a) a power assist system comprising a motion sensing system configured to detect the motion of the power assist system, and a power assist drive system; characterized in that it further comprises a motion sensing system configured to detect the motion of the power assist system, and a power assist drive system; characterized in that it further comprises (b) a sensor configured to detect a motion of a user's hand, the sensor being in communication with the power assist system.
A peptide comprising the amino acid sequence D-Trp-Aib (SEQ ID NO. 30), for use in the prevention and/or treatment of glaucoma in a subject in need thereof, wherein said peptide is administered daily for a first period of at least one day in at least a therapeutically effective dose, followed by a second period of at least one week wherein the peptide is not administered, followed by repeating said first period of at least one day wherein said peptide is administered daily.
A service processing method performed by a system comprising an access point, AP, and a station, STA, the method comprising: • sending, by the AP, second service data to the STA by using a second Media Access Control, MAC, connection between the AP and the STA, wherein the STA has a second MAC address for communicating with the AP by using the second MAC connection; • receiving, by the AP, a connection request that is sent by the STA by using a first MAC address (step 502), and establishing, by the AP, a first MAC connection to the STA according to the first MAC address (step 503), wherein the first MAC address is a MAC address of the STA after the STA changes the second MAC address into the first MAC address (step 2. 504);; • receiving, by the AP, a MAC address change message that is sent by the STA in an encryption mode, wherein the MAC address change message carries the second MAC address of the STA (step 505); • determining, by the AP, according to the MAC address change message that the STA has changed the MAC address (step 506); and • sending, by the AP, first service data to the STA through the first MAC connection by using a resource related to the second MAC connection, wherein the first service data are sent to the STA with an increased data transmission rate compared a data transmission rate of the second service data (step 507). • sending, by the AP, second service data to the STA by using a second Media Access Control, MAC, connection between the AP and the STA, wherein the STA has a second MAC address for communicating with the AP by using the second MAC connection; • receiving, by the AP, a connection request that is sent by the STA by using a first MAC address (step 502), and establishing, by the AP, a first MAC connection to the STA according to the first MAC address (step 503), wherein the first MAC address is a MAC address of the STA after the STA changes the second MAC address into the first MAC address (step 2. 504);; • receiving, by the AP, a MAC address change message that is sent by the STA in an encryption mode, wherein the MAC address change message carries the second MAC address of the STA (step 505); • determining, by the AP, according to the MAC address change message that the STA has changed the MAC address (step 506); and • sending, by the AP, first service data to the STA through the first MAC connection by using a resource related to the second MAC connection, wherein the first service data are sent to the STA with an increased data transmission rate compared a data transmission rate of the second service data (step 507).
A compound having a general formula of Structure 1 or a composition comprising at least one compound having a general formula of Structure 1, as an active ingredient, for use in the treatment of a condition in a human or animal via transdermal administration wherein: R 1 is selected from the group consisting of H, alkyl residues having 1 to 12 carbon atoms, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having up to 12 carbon atoms, and alkynyl residues having up to 12 carbon atoms; R 2 is selected from the group consisting of H, alkyl residues having 1 to 12 carbon atoms, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having up to 12 carbon atoms, and alkynyl residues having up to 12 carbon atoms; R 3 is H; X represents O or 2-OCO-C 6 H 4 -O; A - represents a negative ion; n= 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; and the condition is selected from the group consisting of pain, fever, cancer, dysmenorrhea, radiation-induced vomiting, diabetic neuropathy, hemophilic arthropathy, bone loss, psoriasis, acne, skin disorders, and sunburn. R 1 is selected from the group consisting of H, alkyl residues having 1 to 12 carbon atoms, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having up to 12 carbon atoms, and alkynyl residues having up to 12 carbon atoms; R 2 is selected from the group consisting of H, alkyl residues having 1 to 12 carbon atoms, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having up to 12 carbon atoms, and alkynyl residues having up to 12 carbon atoms; R 3 is H; X represents O or 2-OCO-C 6 H 4 -O; A - represents a negative ion; n= 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; and
A heat exchange system for an indwelling heat exchange catheter, comprising: a heat exchange bath configured to receive a conduit carrying working fluid to and from the catheter; and a flow detector (429, 800) in communication with the conduit for detecting when working fluid is flowing through the conduit, wherein the flow detector (429, 800) comprises: a clear housing; a paddle wheel rotatably disposed in the housing; and at least three infrared transmitter/receiver light emitting diode pairs, each infrared transmitter/receiver light emitting diode pair establishing a signal path through the housing, characterised in that the paddle wheel comprises: at least three paddles, the three paddles being arranged such that one of the signal paths established by the infrared transmitter/receiver light emitting diode pairs is always unblocked by the paddles. a heat exchange bath configured to receive a conduit carrying working fluid to and from the catheter; and a flow detector (429, 800) in communication with the conduit for detecting when working fluid is flowing through the conduit, wherein the flow detector (429, 800) comprises: a clear housing; a paddle wheel rotatably disposed in the housing; and at least three infrared transmitter/receiver light emitting diode pairs, each infrared transmitter/receiver light emitting diode pair establishing a signal path through the housing, characterised in that the paddle wheel comprises: at least three paddles, the three paddles being arranged such that one of the signal paths established by the infrared transmitter/receiver light emitting diode pairs is always unblocked by the paddles. a clear housing; a paddle wheel rotatably disposed in the housing; and at least three infrared transmitter/receiver light emitting diode pairs, each infrared transmitter/receiver light emitting diode pair establishing a signal path through the housing, characterised in that the paddle wheel comprises: at least three paddles, the three paddles being arranged such that one of the signal paths established by the infrared transmitter/receiver light emitting diode pairs is always unblocked by the paddles.
A relay comprising a coil housing having a coil arrangement and a movable armature which, by a magnetic flux which is producible in the coil arrangement by a coil current, permits or interrupts a flow of current via two main contact terminals, characterized in that in the coil housing a control unit is provided for controlling the coil current, which control unit is directly arranged on the coil body and prevents a malfunction of the relay in case of relay voltages that are too weak or too high and applied from outside by the control unit outputting an exactly defined coil current to the coil of the relay.
Method for measuring different particle concentrations using a particle measurement system, comprising a photometric scattered-light unit having a measurement volume, wherein the scattered-light unit consists of at least one light transmitter, which emits pulsed light signals, and of at least one light-sensitive receiver system, which is arranged under at least one angle and receives the scattered light of the particles that form the particle concentration, characterized in that the scattered-light unit having the measurement volume is hermetically sealed with the exception of at least one fluid inlet and/or at least one fluid outlet, which are provided with shut-off devices (2, 3), wherein the scattered-light unit having the measurement volume receives a sample of the fluid to be investigated and the first and/or second shut-off apparatus (2, 3) is/are closed and a flow of the fluid to be investigated is generated in the completely hermetically sealed scattered-light unit and a predeterminable first number of measurement values is recorded.
A method of creating a composite cable (10, 24, 26) with a high-performance termination on one end, wherein the performance of said high-performance termination is pre-qualified, comprising: a. providing a short cable, having a first end and a second end; b. locking said second end of said short cable into a high-performance termination; c. applying a defined test load to said short cable, wherein said defined test load is applied through said high-performance termination in order to determine whether said short cable and said high-performance termination pass a defined test criterion; d. providing a long cable, having a first end and a second end; and e. after said short cable passes said defined test criterion, joining said first end of said short cable to said second end of said long cable to form said composite cable (10, 24, 26) having a high-performance termination on one end. a. providing a short cable, having a first end and a second end; b. locking said second end of said short cable into a high-performance termination; c. applying a defined test load to said short cable, wherein said defined test load is applied through said high-performance termination in order to determine whether said short cable and said high-performance termination pass a defined test criterion; d. providing a long cable, having a first end and a second end; and e. after said short cable passes said defined test criterion, joining said first end of said short cable to said second end of said long cable to form said composite cable (10, 24, 26) having a high-performance termination on one end.
A nasal fluid-spray device comprising: a reservoir containing at least one dose of fluid; and a dispenser system that, each time the device is actuated, sprays a dose of fluid through a spray orifice, generating a spray that extends axially from said spray orifice; said device being characterized in that it further comprises a generator system for generating a secondary flow, which generator system is actuated simultaneously with said dispenser system, said secondary flow generator system comprising a secondary flow channel that is provided with an outlet orifice, said outlet orifice being arranged downstream from said spray orifice in the axial direction of said spray, and said secondary flow extending from said outlet orifice along an axis that forms an angle (α) relative to the axis of said spray and that intersects said axis, thereby deforming and/or deflecting said spray.
A process for manufacturing a polycarbonate with a glass transition temperature of greater than or equal to 50°C, characterized in that it comprises: ▪ a step of introducing, into a reactor, a monomer of formula: R1 and R2 being identical or different alkyl groups; ▪ a step of introducing, into the reactor, at least one cyclic diol or a mixture of diols comprising at least 20 mol% of cyclic diols; ▪ a subsequent step of polycondensation by transesterification of the monomer mixture comprising monomers and; ▪ a step of recovering the polycarbonate formed in step. ▪ a step of introducing, into a reactor, a monomer of formula: R1 and R2 being identical or different alkyl groups; ▪ a step of introducing, into the reactor, at least one cyclic diol or a mixture of diols comprising at least 20 mol% of cyclic diols; ▪ a subsequent step of polycondensation by transesterification of the monomer mixture comprising monomers and; ▪ a step of recovering the polycarbonate formed in step.
An illuminated ophthalmic microsurgical instrument comprising: a microsurgical instrument (46,48,50,51) having a distal tip; and an optical fiber for delivering a beam of light to a surgical site in an eye, the optical fiber including a proximal end for receiving a light beam from a light source, and a distal end proximate to the distal tip of the microsurgical instrument for emitting the light beam, characterized in that the distal end includes a beveled end face oriented away from the distal tip of the microsurgical instrument, at an oblique angle with respect to an optical axis of the optical fiber, wherein the optical fiber has an index of refraction which is greater than an index of refraction of a vitreous region of the eye such that a propagation path of the light beam from the beveled end face is refracted towards the microsurgical instrument, when used to perform an ophthalmic surgical procedure. a microsurgical instrument (46,48,50,51) having a distal tip; and an optical fiber for delivering a beam of light to a surgical site in an eye, the optical fiber including a proximal end for receiving a light beam from a light source, and a distal end proximate to the distal tip of the microsurgical instrument for emitting the light beam, characterized in that the distal end includes a beveled end face oriented away from the distal tip of the microsurgical instrument, at an oblique angle with respect to an optical axis of the optical fiber, wherein the optical fiber has an index of refraction which is greater than an index of refraction of a vitreous region of the eye such that a propagation path of the light beam from the beveled end face is refracted towards the microsurgical instrument, when used to perform an ophthalmic surgical procedure.
An ADP ribosyl cyclase antagonist or nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist compound for use in preventing or treating myopathy or treating muscle trauma in a subject, the myopathy not being uraemic myopathy, characterised in that the ADP ribosyl cyclase is CD38 and in that the CD38 antagonist compound is a compound of formula: in which: - R 1 = H, C 3 H 7, C 4 H 9, C 6 H 13, C 12 H 25, CH 2 -benzene or CH 2 -CH 2 -Benzene group; - R 2 = S, OH, - R 3 = F, CN, Br, Cl and/or - R 4 = CONH 2, COOH, COCN, or COF; and the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist compound is NAADP of formula: at a concentration of at least 100 μmolar; and/or a mixture of at least two of the said compounds. - R 1 = H, C 3 H 7, C 4 H 9, C 6 H 13, C 12 H 25, CH 2 -benzene or CH 2 -CH 2 -Benzene group; - R 2 = S, OH, - R 3 = F, CN, Br, Cl and/or - R 4 = CONH 2, COOH, COCN, or COF; and the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist compound is NAADP of formula: at a concentration of at least 100 μmolar; and/or a mixture of at least two of the said compounds.
Autoinjector comprising an external shell, a reservoir containing fluid product and comprising a piston and a needle, such as a pre-filled syringe, said autoinjector comprising a piston rod adapted to cooperate with the piston of said reservoir, said piston rod being moveable between a loaded position and an injection position in which said piston rod has moved the piston of the reservoir to inject the fluid product through the needle, an injection spring being provided to stress said piston rod towards its injection position, the autoinjector comprising a control sleeve, containing said piston rod and said injection spring, said piston rod being moveable relative to said control sleeve during the injection phase, said autoinjector comprising a sound and/or tactile indication device comprising a central piece connected to said piston rod by a wire, said piston rod, on completion of injection, exerting via said wire traction on said central piece, characterized in that said central piece is connected to at least one lateral piece by a foldable and/or breakable link, so that said traction on said central piece causes deformation and/or rupture of said at least one foldable and/or breakable link and thus deformation and/or movement of said at least one lateral piece, allowing axial movement of said control sleeve under the effect of said injection spring, said movement generating a sound and/or tactile indication for the user.
A polyolefin-based structure comprising 60 to 97% by mass of a polyolefin, 1 to 35% by mass of an acid-modified polyolefin, and 2 to 35% by mass of a polyamide resin, wherein the polyamide resin is dispersed in a layered form in the polyolefin, and the polyamide resin is a melt-kneaded product of 30 to 70% by mass of a polyamide that contains a diamine unit containing 70 mol% or more of a m-xylylenediamine unit and a dicarboxylic acid unit containing an α,ω-linear aliphatic dicarboxylic acid unit and 30 to 70% by mass of an aliphatic polyamide, provided that a total of the polyamide and the polyamide is taken as 100% by mass, and a difference between a melting point Tm 0 of the polyamide as observed by differential scanning calorimetry and a melting point Tm, derived from the polyamide in the polyamide resin, is from 0.1 to 2.5°C.
Solid composition for the preparation of an aqueous solution for application on fresh produce, the solid composition comprising potassium carbonate and at least one source of ascorbate and/or isoascorbate ions and optionally excipients, wherein the molar ratio of potassium cations to ascorbate anions and/or isoascorbate anions in the solid composition is within the range from 1.00: 0.95 to 1.00: 0.50; preferably 1.00: ≤ 0.78 to 1.00: 0.5; the source of ascorbate ions and/or isoascorbate ions is ascorbic acid or a salt thereof and/or isoascorbic acid or a salt thereof or acerola or any other suitable ascorbic acid rich source.
An orthopedic drill guide assembly comprising: an elongated body having first and second ends; a first arm member extending from said first end of the elongated body; a second arm member extending from said elongated body and configured and adapted to be longitudinally movable along said elongated body; one of the two arm members (106, 110) provided with a guide housing; and a sleeve having a longitudinal bore, wherein said guide housing is configured and adapted to removably receive said sleeve, characterized in that the first arm member is provided with a first clamp engaging hole and the second arm member is provided with a second clamp engaging hole, the first and the second clamp engaging holes being configured to be engaged to a clamp for compressing the second arm member towards the first arm member. an elongated body having first and second ends; a first arm member extending from said first end of the elongated body; a second arm member extending from said elongated body and configured and adapted to be longitudinally movable along said elongated body; one of the two arm members (106, 110) provided with a guide housing; and a sleeve having a longitudinal bore, wherein said guide housing is configured and adapted to removably receive said sleeve, characterized in that the first arm member is provided with a first clamp engaging hole and the second arm member is provided with a second clamp engaging hole, the first and the second clamp engaging holes being configured to be engaged to a clamp for compressing the second arm member towards the first arm member.
Belt frame for a vehicle seat or a vehicle seat bench, wherein attachment means for attaching to a structure of a vehicle in the region of a vehicle floor are present on the belt frame, wherein the belt frame comprises a restraint member (20, 21), wherein the restraint member (20, 21) is arranged on the belt frame at a vertical distance from the attachment means for attaching the belt frame to the structure of the vehicle, and wherein the restraint member (20, 21) is designed to be arranged at a holding point (27, 28) of the structure of the vehicle, wherein, in the state of the belt frame arranged on the vehicle, the holding point (27, 28) is present in a region behind a rear side of the belt frame with respect to a direction of travel F, characterized in that the restraint member (20, 21) is mounted at a mounting point (45, 46) of the belt frame, wherein the mounting point (45, 46) is present on the belt frame in a range of 100 mm to 650 mm starting from an erecting surface of the belt frame for erecting on the vehicle floor as seen in a vertical extent of the belt frame upwards, wherein the restraint member (20, 21) is present in such a manner that a deformation of the belt frame, which is arranged on the structure (4, 12) of a vehicle, can be predetermined in the event of loading.
Surgical tissue fusion instrument (1, 1a, 1b, 1c) with two gripping structures (2, 3; 2a, 3a; 2b, 3b; 2c, 3c) which are movable relative to each other, are designed for gripping and bringing together biological tissue sections, and are assigned heat-generating means designed in such a way that tissue fusion takes place between the biological tissue sections by heat being supplied in the area of the gripping structures, wherein at least one gripping structure (2, 3; 2a, 3a; 2b, 3b; 2c, 3c) is assigned a fluid-conducting system, which is designed to supply at least one liquid or flowable additive to the tissue sections during a tissue fusion procedure, wherein the fluid-conducting system has at least one fluid-conducting channel (7, 8; 14; 18, 18b), which is integrated in one of the two gripping structures and at least one gripping structure (2, 3; 2a, 3a; 2b, 3b) is provided with fluid outlet openings (5, 15, 19; 19b), into which the at least one fluid-conducting channel (7, 8; 14; 18; 18b) opens, wherein the fluid-conducting system has at least one fluid reservoir (7, 8; 13; 17; 17b), which is connected to the fluid-conducting channel (7, 8; 14; 18; 18b), wherein the fluid reservoir (13, 17, 17b) and/or the fluid-conducting channel (7, 8, 14, 18, 18b) has a reservoir volume that is variable depending on an actuation mechanism, wherein the actuation mechanism is operatively connected to an actuation unit for bringing together the gripping structures (2, 3; 2a, 3a; 2b, 3b), wherein the fluid outlet openings (5, 15, 19, 19b) are integrated in at least one electrode arrangement (6, 6a, 6b), which is assigned to the heat-generating means, wherein the fluid outlet openings are provided in a movably mounted actuation wall of the at least one fluid-conducting channel (7, 8) or fluid reservoir, which actuation wall, depending on an activation of the actuation unit, is movable in order to bring together the gripping structures, characterized in that the actuation wall is formed by an electrode wall of the electrode arrangement (6, 6a, 6b).